Episode 292: ASCO GU 2024 - HPN328; A Tri-Specific T Cell Engager in Prostate Cancer

Himisha Beltran, MD, describes the activity of this novel agent in neuroendocrine prostate cancer.
Dr. Beltran is an Associate Professor of Medicine in the Lank Center for Genitourinary Oncology at Dana-Farber Cancer Institute, and serves as the Director of Translational Research within Medical Oncology.